| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-70 |
Sentence |
denotes |
Developmental changes in neutral glycosphingolipids of mouse placenta. |
| T1 |
0-70 |
Sentence |
denotes |
Developmental changes in neutral glycosphingolipids of mouse placenta. |
| TextSentencer_T2 |
71-151 |
Sentence |
denotes |
The mammalian placenta is a unique organ for the study of developmental changes. |
| T2 |
71-151 |
Sentence |
denotes |
The mammalian placenta is a unique organ for the study of developmental changes. |
| TextSentencer_T3 |
152-308 |
Sentence |
denotes |
Placentas of laboratory animals such as the mouse allow for the determination of the exact stage of pregnancy, which cannot be achieved with human placenta. |
| T3 |
152-308 |
Sentence |
denotes |
Placentas of laboratory animals such as the mouse allow for the determination of the exact stage of pregnancy, which cannot be achieved with human placenta. |
| TextSentencer_T4 |
309-512 |
Sentence |
denotes |
In this study, neutral glycosphingolipids were isolated from mouse (inbred strain C57BL/6) placentas, from day 10 to day 18 of gestation, and were separated by high performance thin layer chromatography. |
| T4 |
309-512 |
Sentence |
denotes |
In this study, neutral glycosphingolipids were isolated from mouse (inbred strain C57BL/6) placentas, from day 10 to day 18 of gestation, and were separated by high performance thin layer chromatography. |
| TextSentencer_T5 |
513-714 |
Sentence |
denotes |
Densitometric measurements after orcinol staining showed, at day 10 of gestation, the presence of mono-, tetra-, tri- and dihexosylceramide in decreasing quantities, as well as four unidentified spots. |
| T5 |
513-714 |
Sentence |
denotes |
Densitometric measurements after orcinol staining showed, at day 10 of gestation, the presence of mono-, tetra-, tri- and dihexosylceramide in decreasing quantities, as well as four unidentified spots. |
| TextSentencer_T6 |
715-968 |
Sentence |
denotes |
On day 12, the glycosphingolipid composition changed with the disappearance of the unidentified spots and the appearance of an orcinol positive migrating similarly to the Forssman antigen; no further changes occurred between days 12 and 18 of gestation. |
| T6 |
715-968 |
Sentence |
denotes |
On day 12, the glycosphingolipid composition changed with the disappearance of the unidentified spots and the appearance of an orcinol positive migrating similarly to the Forssman antigen; no further changes occurred between days 12 and 18 of gestation. |
| TextSentencer_T7 |
969-1321 |
Sentence |
denotes |
The identity of the Forssman-like glycosphingolipid with the Forssman antigen was established by binding of 125I labelled Helix pomatia agglutinin (alpha-GalNAc specific) to glycosphingolipids separated on high performance thin layer chromatography plates, and by the reaction of the isolated glycosphingolipid with a monoclonal anti-Forssman antibody. |
| T7 |
969-1321 |
Sentence |
denotes |
The identity of the Forssman-like glycosphingolipid with the Forssman antigen was established by binding of 125I labelled Helix pomatia agglutinin (alpha-GalNAc specific) to glycosphingolipids separated on high performance thin layer chromatography plates, and by the reaction of the isolated glycosphingolipid with a monoclonal anti-Forssman antibody. |
| TextSentencer_T8 |
1322-1566 |
Sentence |
denotes |
The appearance of the Forssman antigen at day 12 of gestation coincided with the day of final maturation of the mouse placenta and subsequent cessation of growth, suggesting a possible role of the glycosphingolipid during embryonic development. |
| T8 |
1322-1566 |
Sentence |
denotes |
The appearance of the Forssman antigen at day 12 of gestation coincided with the day of final maturation of the mouse placenta and subsequent cessation of growth, suggesting a possible role of the glycosphingolipid during embryonic development. |
